The CM-Path workshop ‘Current and Future Challenges for Innovative Biomarker Development’ was organised by Dr Maggie Cheang and held on…
CM-Path Consumer Spends a Day in the Glasgow Diagnostic Pathology Lab
'CM-Path members Dr Jane Hair (Discovery Workstream), Dr Hayley Morris (Skills and Capacity Workstream Trainee), Dr Tomoko Iwata (Skills and…
CM-Path Recognises the Need for Quality Assurance in Clinical Trials
'Dr Clare Verrill organised a meeting on the 21st March 2017 attended by CM-Path members, as well as representatives from…
CM-Path and RCPath Host “A Pathologist’s Guide to Research and Clinical Trials”
'On December 9th 2016, CM-Path and the Royal College of Pathologists hosted a joint workshop aimed at pathologists that want…
CM-Path Hosts Industry Engagement Day
'On October 5th 2016, CM-Path invited industry representatives from pharmaceutical, molecular diagnostic and digital pathology companies to attend a workshop…
NCRI’s CM-Path initiative successfully launched
'The launch of NCRI’s Cellular Molecular Pathology initiative (CM-Path) took place on 6 June. Funders, NCRI Partners, consumers and CM-Path…
The CM-Path Initiative Launches
'On June 6th 2016, CM-Path members, funders and NCRI colleagues gathered in London for the intiative’s launch. » Download the…
The CM-Path launch set to take place on Monday 6th June
'On Monday 6th June, CM-Path members and funders will come together for the first time to set clear objectives and…
Interview with Dr Alex Freeman, member of NCRI’s CM-Path
'To mark International Clinical Trials Day this year we speak to Dr Alex Freeman, Consultant Histopathologist at University College London…
NCRI CM-Path Workstream Lead appointments and launch date
'CM-Path is NCRI’s newest initiative, which aims to reinvigorate pathology research in the UK. Following the appointment of the CM-Path…
Dr Karin Oien appointed Chair of NCRI’s new initiative in Cellular Molecular Pathology
'Following agreement of funding for the new NCRI Cellular Molecular Pathology (CM-Path) initiative and a recruitment call for key roles in the…
New funding for pathology is keeping cancer research at the cutting edge
'MORE THAN half a million pounds has been committed to a new initiative called Cellular Molecular Pathology (CM-Path) which aims…